Antiviral therapy for chronic hepatitis D. European Commission grants full approval for bulevirtide (Hepcludex®)

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2023年 / 39卷 / 05期
关键词：
D O I：
10.1159/000534345
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 19 条
  • [1] EFFECT OF BULEVIRTIDE TREATMENT ON THE HDV INDUCED ANTIVIRAL STATE AND CELL DAMAGE IN INFECTED HUMANIZED MICE AND PATIENTS WITH CHRONIC HEPATITIS D
    Dandri, Maura
    Volz, Tassilo
    Allweiss, Lena
    Manuilov, Dmitry
    Fletcher, Simon
    Holdorf, Meghan
    Muench, Robert
    Downie, Bryan
    Wallin, Jeffrey
    HEPATOLOGY, 2024, 80 : S127 - S127
  • [2] HEllenic multicenter ReAl-life CLInical Study for bulevirtide therapy in chronic hepatitis D (HERACLIS_BLV_D)
    Papatheodoridi, Margarita
    Sevastianos, Vasilios
    Zachou, Kalliopi
    Christodoulou, Dimitrios
    Koskinas, Ioannis
    Deutsch, Melanie
    Alexopoulou, Alexandra
    Elefsiniotis, Ioannis
    Triantos, Christos
    Gigi, Eleni
    Androutsakos, Theodoros
    Karagiannakis, Dimitrios
    Mani, Iliana
    Dimitroulopoulos, Dimitrios
    Mela, Maria
    Sinakos, Emmanouil
    Michopoulos, Spyridon
    Mimidis, Konstantinos
    Papadopoulos, Nikolaos
    Kontos, Athanasios
    Veteranos, Christos
    Lymberopoulos, Dimitrios
    Giannoulis, George
    Papadimitropoulos, Vasilios
    Avramopoulou, Evdoxia
    Pantzios, Spyridon
    Vasilieva, Larisa
    Kranidioti, Hariklia
    Koullias, Emmanouil
    Psychos, Nikolaos
    Fytili, Paraskevi
    Vlachogiannakos, Ioannis
    Cholongitas, Evangelos
    Manolakopoulos, Spilios
    Goulis, Ioannis
    Dalekos, George
    Papatheodoridis, George
    JOURNAL OF HEPATOLOGY, 2024, 80 : S798 - S799
  • [3] European Commission grants Approval for Nivolumab plus Ipilimumab as First-line Therapy for Patients with advanced Renal Cell Cancer with intermediate or unfavorable Risk Profile
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 158 - 158
  • [4] Modeling-based response-guided therapy with bulevirtide monotherapy for chronic hepatitis D to identify patients for finite treatment duration
    Duehren, Sarah
    Shekhtman, Louis
    Cotler, Scott
    Aberle, Stephan
    Reiberger, Thomas
    Ferenci, Peter
    Dahari, Harel
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1170 - S1171
  • [5] Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
    Jachs, Mathias
    Sauberer, Raphael
    Stiegler, Alexander
    Dechene, Anton
    Tazreiter, Raphael
    Hartl, Lukas
    Bauer, David
    Balcar, Lorenz
    Strassl, Robert
    Mandorfer, Mattias
    Trauner, Michael
    Munda, Petra
    Ferenci, Peter
    Reiberger, Thomas
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (03) : 293 - 304
  • [6] Vitamin D Levels May Explain the Racial Differences in Response Rates to Antiviral Therapy for Chronic Hepatitis C
    Ji, Hong-Fang
    HEPATOLOGY, 2011, 54 (04) : 1489 - 1489
  • [7] H63D HFE gene mutation is a positive predictive factor to response to antiviral therapy in chronic hepatitis C
    Lebray, P
    Zylberberg, H
    Hue, S
    Martin, S
    Chrétien, Y
    Poulet, B
    Nalpas, B
    Pol, S
    Caillat-Zuckman, S
    Bréchot, C
    JOURNAL OF HEPATOLOGY, 2000, 32 : 113 - 113
  • [8] BASELINE SERUM VITAMIN D LEVELS STRONGLY PREDICT THE ACHIEVEMENT OF SUSTAINED VIRAL RESPONSE AFTER ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C
    Bitetto, Davide
    Fattovich, Giovanna
    Ceriani, Elisa
    Pasino, Michela
    Cristofori, Chiara
    Cussigh, Annarosa
    Fabris, Carlo
    Fornasiere, Ezio
    Cmet, Sara
    Falleti, Edmond
    Pirisi, Mario
    Toniutto, Pierluigi
    HEPATOLOGY, 2010, 52 (04) : 790A - 791A
  • [9] Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
    Wagner, Josef
    Yuen, Lilly
    Littlejohn, Margaret
    Sozzi, Vitina
    Jackson, Kathy
    Martin, Ross
    Aeschbacher, Thomas
    Suri, Vithika
    Tan, Susanna K.
    Feierbach, Becket
    Gaggar, Anuj
    Marcellin, Patrick
    Ferret, Maria Buti
    Janssen, Harry L. A.
    Gane, Ed
    Meagher, Niamh
    Price, David J.
    Wong, Darren
    Thompson, Alexander T.
    Revill, Peter A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (05) : 509 - 523
  • [10] Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
    Sandmann, Lisa
    Berg, Thomas
    Deterding, Katja
    Fischer, Nadine
    Hinrichsen, Holger
    Petersen, Joerrg
    Tacke, Frank
    Cornberg, Markus
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (12): : E715 - E732
12